drug developed pfizer treatment erectile dysfunction nonpeptide agonist selective melanocortin receptor subtype found active preliminary human trials dose similar effectiveness sildenafil though lower doses ineffective unclear whether potent effective enough developed medical use demonstrated selectively targeting subtype produce similar aphrodisiac effects older nonselective peptidebased melanocortin receptor agonists like melanotan ii bremelanotide without side effects caused action melanocortin receptor drug article relating genitourinary system stub help wikipedia expanding